1990
DOI: 10.1210/mend-4-8-1211
|View full text |Cite
|
Sign up to set email alerts
|

Expression of Preprotachykinin-A and Neuropeptide-Y Messenger RNA in the Thymus

Abstract: The preprotachykinin-A gene, the common gene of mRNAs encoding both substance-P (SP) and neurokinin-A (NKA), was shown to be expressed in Sprague-Dawley rat thymus by detection of specific mRNA in gel-blot analyses. In situ hybridization revealed dispersed PPT-A-labeled cells in sections from rat thymus, with a concentration of grains over a subpopulation of cells in the thymic medulla. Also, neuropeptide-Y mRNA-expressing cells were found in the rat thymus, primarily in the thymic medulla. Rat thymic extracts… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
28
0
3

Year Published

1994
1994
2008
2008

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 67 publications
(33 citation statements)
references
References 46 publications
2
28
0
3
Order By: Relevance
“…Somehow like the transduction following the binding of a signal to its receptor, the immunological recognition of OT leads to TEC activation reflected here by the secretion of IL-6 and LIF. It will be also of interest to determine whether Abs against other thymic self-antigens such as neurokinin A [39] and insulin-like growth factor II [40,41] are also able to affect TEC secretory activity. At the present stage, this study supports our model on the dual physiological role played in T-cell differentiation by the thymic repertoire of neuroendocrine-related polypeptides [8,9].…”
Section: Discussionmentioning
confidence: 99%
“…Somehow like the transduction following the binding of a signal to its receptor, the immunological recognition of OT leads to TEC activation reflected here by the secretion of IL-6 and LIF. It will be also of interest to determine whether Abs against other thymic self-antigens such as neurokinin A [39] and insulin-like growth factor II [40,41] are also able to affect TEC secretory activity. At the present stage, this study supports our model on the dual physiological role played in T-cell differentiation by the thymic repertoire of neuroendocrine-related polypeptides [8,9].…”
Section: Discussionmentioning
confidence: 99%
“…Toutefois, nos travaux ont démontré que les cellules épithéliales thymiques (CET) sont le siège de la transcription d'un grand nombre de gènes appartenant à plusieurs familles neuroendocrines, comme celles des hormones neurohypophysaires [9], des tachykinines [10], de la neurotensine [11] et de l'insuline [12]. La nature du « soi neuroendocrine » a été ensuite définie comme suit :…”
Section: La Nature Du Soi Neuroendocrineunclassified
“…La liaison de l'ocytocine à son récepteur exprimé par les cellules T thymiques provoque une phosphorylation rapide des kinases liées à l'adhésion focale [13], qui pourrait jouer un rôle dans la promotion de synapses immunologiques entre les cellules thymiques présentatrices d'antigènes (CPA), comme les CET et les cellules T immatures. La neurokinine A -et non la substance P -est le peptide généré par l'apprêtement dans les CET du produit d'expression du gène de la préprotachykinine A [10]. En ce qui concerne la famille de l'insuline, l'expression thymique du facteur de croissance apparenté à l'insuline de type 2 (IGF-2) prédomine pendant la vie foetale sur celle de l'IGF-1, elle-même étant supérieure à celle de l'insuline (12 ; Hansenne et al, soumis pour publication).…”
Section: La Nature Du Soi Neuroendocrineunclassified
“…The repertoire of thymic neuroendocrine precursors expressed is organized in such a way that one dominant member per family is expressed in the thymus. Thymic neuroendocrine selfantigens usually correspond to sequences highly conserved throughout evolution of one given family: oxytocin (OT) vs. vasopressin (VP) for the family of related hormones, neurokinin A vs. substance P for tachykinins (Ericsson et al, 1990), and insulin-like growth factor 2 (IGF-2) vs. IGF-1 and proinsulin for the insulin family (Geenen et al, 1993;Martens et al, 1996a).…”
Section: Introductionmentioning
confidence: 99%